Deutsche Bank’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-8,000
| Closed | -$6K | – | 5226 |
|
|
2019
Q4 | $6K | Hold |
8,000
| – | – | ﹤0.01% | 4648 |
|
|
2019
Q3 | $4K | Hold |
8,000
| – | – | ﹤0.01% | 4726 |
|
|
2019
Q2 | $4K | Hold |
8,000
| – | – | ﹤0.01% | 5137 |
|
|
2019
Q1 | $3K | Hold |
8,000
| – | – | ﹤0.01% | 5070 |
|
|
2018
Q4 | $3K | Hold |
8,000
| – | – | ﹤0.01% | 5054 |
|
|
2018
Q3 | $4K | Hold |
8,000
| – | – | ﹤0.01% | 5216 |
|
|
2018
Q2 | $4K | Hold |
8,000
| – | – | ﹤0.01% | 5284 |
|
|
2018
Q1 | $3K | Sell |
8,000
-250
| -3% | -$101 | ﹤0.01% | 5298 |
|
|
2017
Q4 | $3K | Hold |
8,250
| – | – | ﹤0.01% | 4907 |
|
|
2017
Q3 | $2K | Sell |
8,250
-99
| -1% | -$37 | ﹤0.01% | 4813 |
|
|
2017
Q2 | $3K | Buy |
8,349
+99
| +1% | +$40 | ﹤0.01% | 4817 |
|
|
2017
Q1 | $3K | Buy |
8,250
+35
| +0.4% | +$15 | ﹤0.01% | 4764 |
|
|
2016
Q4 | $3K | Hold |
8,215
| – | – | ﹤0.01% | 4803 |
|
|
2016
Q3 | $2K | Hold |
8,215
| – | – | ﹤0.01% | 4840 |
|
|
2016
Q2 | $1K | Buy |
8,215
+215
| +3% | +$37 | ﹤0.01% | 5142 |
|
|
2016
Q1 | $0 | Hold |
8,000
| – | – | ﹤0.01% | 5647 |
|
|
2015
Q4 | $0 | Hold |
8,000
| – | – | ﹤0.01% | 5663 |
|
|
2015
Q3 | $1K | Hold |
8,000
| – | – | ﹤0.01% | 5168 |
|
|
2015
Q2 | $5K | Hold |
8,000
| – | – | ﹤0.01% | 5169 |
|
|
2015
Q1 | $5K | Hold |
8,000
| – | – | ﹤0.01% | 4915 |
|
|
2014
Q4 | $6K | Hold |
8,000
| – | – | ﹤0.01% | 5861 |
|
|
2014
Q3 | $3K | Sell |
8,000
-100
| -1% | -$49 | ﹤0.01% | 5644 |
|
|
2014
Q2 | $4K | Buy |
8,100
+100
| +1% | +$48 | ﹤0.01% | 5677 |
|
|
2014
Q1 | $2K | Hold |
8,000
| – | – | ﹤0.01% | 5401 |
|
|
2013
Q4 | $2K | Sell |
8,000
-700
| -8% | -$846 | ﹤0.01% | 5239 |
|
|
2013
Q3 | $17K | Hold |
8,700
| – | – | ﹤0.01% | 4933 |
|
|
2013
Q2 | $16K | Buy |
+8,700
| New | +$15.3K | ﹤0.01% | 4827 |
|
Deutsche Bank's GCVRZ Position: Q1 2020 in Review
Deutsche Bank sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 8,000 shares — an estimated $6K sold.
Deutsche Bank first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $17K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Deutsche Bank reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Deutsche Bank sold 8,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $6K.
- Deutsche Bank first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Deutsche Bank's Sanofi Contingent Value Rights position peaked at $17K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.